Praxis Precision Medicines (NASDAQ: PRAX) said the U.S. Food and Drug Administration granted Breakthrough Therapy Designation (BTD) for elsunersen, an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE